SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-030238
Filing Date
2018-05-03
Accepted
2018-05-03 15:30:03
Documents
5
Period of Report
2018-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-12719_18k.htm 8-K 26203
2 UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND LEERINK PARTNERS LLC, DATED MAY 2 a18-12719_1ex1d1.htm EX-1.1 338824
3 OPINION OF RUTGERS POSCH VISEE ENDEDIJK N.V. a18-12719_1ex5d1.htm EX-5.1 56381
4 PRESS RELEASE DATED MAY 2, 2018, ENTITLED "UNIQURE ANNOUNCES PRICING OF ITS PUBL a18-12719_1ex99d1.htm EX-99.1 16039
5 GRAPHIC g127191mmi001.jpg GRAPHIC 3618
  Complete submission text file 0001104659-18-030238.txt   443719
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 18803505
SIC: 2834 Pharmaceutical Preparations